Picture of Mast Energy Developments logo

MAST Mast Energy Developments News Story

0.000.00%
gb flag iconLast trade - 00:00
UtilitiesHighly SpeculativeMicro CapNeutral

REG - Mast Energy Dvlpmts. - Annual Financial Report

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250430:nRSd7164Ga&default-theme=true

RNS Number : 7164G  Mast Energy Developments PLC  30 April 2025

 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

("MED" or "the Company")

 

 

Audited results for the year ended 31 December 2024

 

 

Dated 30 April 2025

 

MAST Energy Developments PLC ('MED' or the 'Company'), is pleased to announce
its audited results for the year ended 31 December 2024. A condensed set of
financial statements accompanies this announcement below while the Company's
full Annual Report and Financial Statements (Audited Annual Report and
Accounts for the year ended 31 December 2024) can be found at the Company's
website at www.med.energy.

 

The Company's Notice of Annual General Meeting will be announced separately in
due course.

 

Overview of key events during the period up to the date of this report

 

·    Revenue increased 77% year-on-year, which were predominantly earned
from July 2024 during the last 6 months of the year, as a result of the
comprehensive refurbishment programme started at the Pyebridge site earlier in
2024 in partnership with RiverFort Global Opportunities PCC Limited
("RiverFort"), and the successful completion of the overhaul of two engines at
the Pyebridge site.

 

·    Loss per share improved significantly with 78% from 1.51 pence in
2023 to 0.32 pence in 2024.

 

·    The comprehensive refurbishment programme at Pyebridge included the
overhaul of two engines at the Pyebridge site and other technical upgrades.
The overhauled engines achieved full commercial operation in July 2024 and
December 2024 respectively and are operating at optimum efficiency, providing
a combined 5.4MW of power generation capacity.

 

·    Company successfully secured alternative funding under a loan
facility for up to £4m with RiverFort further to an agreement with MED
subsidiary Pyebridge Power Ltd ("Pyebridge") on 28 February 2024.  This loan
facility on which the Company made three gross drawdowns during 2024 totalling
£2,769,297 enabled the comprehensive refurbishment at Pyebridge.
Subsequently, repayments to the value of £529,969 were made up to year-end,
and cumulative repayments to date totals £637,969.

 

·    MED's Pyebridge site has secured uninterrupted Capacity Market
contracts to ensure minimum gross profit margin income totalling
c. £1,7m until 2029, in addition to its trading revenue generation via its
PPA with Statkraft.

 

·    MED entered into a long-term Growth Capital Partnership with a
long-established and successful UK flexible power developer and operator,
Powertree (Holdings) Ltd ("Powertree"). As part of this Partnership, Powertree
and ADV 001 Limited (MED's special purpose vehicle ("SPV") holding the Hindlip
Project), signed a comprehensive investment agreement for the construction of
Hindlip to provide capital funding for Hindlip up to £5m, resulting in the
Hindlip site being fully funded with no further funding obligation from MED.

 

·    Following a successful turnaround during 2024, and with the ongoing
support of its two new funding partners, RiverFort and Powertree, MED is now
well positioned to grow its portfolio of MWs in production at some pace to
achieve its target of 300+.

 

 

 

This announcement contains inside information for the purposes of the UK
version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of
United Kingdom domestic law by virtue of the European Union (Withdrawal) Act
2018 ("UK MAR"). Upon the publication of this announcement, this inside
information is now considered to be in the public domain.

 

ENDS

 

For further information please visit www.med.energy or contact:

 

 Pieter Krügel      info@med.energy      Mast Energy Developments plc  CEO
 Jon Belliss        +44 (0)20 7399 9425  Novum Securities              Corporate Broker
 Guy Wheatley, CFA  +44 (0)74 9398 9014  Fortified Securities          Corporate Broker

 

 

DIRECTORS, OFFICERS AND PROFESSIONAL ADVISERS

 

 BOARD OF DIRECTORS:        Paul Venter (Non-Executive Chairman)
                            Pieter Krügel (Chief Executive Officer)

 REGISTERED OFFICE AND      Salisbury House
 BUSINESS ADDRESS:          London Wall
                            London
                            EC2M 5PS

 COMPANY SECRETARY:         Noel Flannan O'Keeffe
                            Salisbury House
                            London Wall
                            London
                            EC2M 5PS

 PLACE OF INCORPORATION:    England & Wales

 AUDITORS:                  Crowe U.K. LLP
                            55 Ludgate Hill
                            London
                            EC4M 7JW

 BROKERS:                   Novum Securities Limited
                            2nd Floor 57 Berkeley Square
                            London
                            W1J 6ER

                            Fortified Securities
                            9 Dalton House
                            60 Windsor Avenue
                            London
                            SW19 2RR

 REGISTRAR:                 MUFG Corporate Markets
                            Unit 10, Central Square
                            29 Wellington Street
                            Leeds
                            LS1 4DL

 SOLICITORS:                Druces LLP
                            Salisbury House
                            London Wall
                            London
                            EC2M 5PS

 PRINCIPLE BANKERS:         Barclays Bank PLC
                            1 Churchill Place
                            Canary Wharf
                            London E14 5HP

 STOCK EXCHANGE LISTING:    London Stock Exchange: Main Market (Share code: MAST)

 WEBSITE:                   www.med.energy

 DATE OF INCORPORATION:     17 September 2020

 REGISTERED NUMBER:         12886458

 

CHAIRMANS REPORT

 

I am pleased to provide a review of MAST Energy Developments PLC ("MED" or the
"Company") and its subsidiaries (collectively, the "Group") activities and
audited financial statements for the year ended 31 December 2024.

 

The past year has seen the Company turn a corner in pursuing its business
strategy to expand its operations in the flexible power generation market in
the United Kingdom following some set-backs in 2023 beyond its expectation or
control, which saw the Company terminate the joint venture agreements with two
investors because of failure of said investors to fulfil their contractual
obligations. In early 2024, the Company successfully secured alternative
funding under a loan facility for up to £4m with institutional investor,
RiverFort Global Opportunities PCC Limited ("RiverFort") further to an
agreement signed with MED subsidiary Pyebridge Power Ltd ("Pyebridge") on 28
February 2024.  This loan facility on which the Company made three gross
drawdowns during 2024 totalling £2,769,297 enabled the Company to pursue a
comprehensive refurbishment programme and successful completion of the
overhaul of two of the engines at our Pyebridge flexible power generation
site. The Company repaid the Pyebridge loan facility owing to RiverFort to the
value of £529,969 during the year, resulting in a net balance owing at
year-end amounting to £2,239,328. The results of the positive progress at
Pyebridge can clearly be seen from the Company's regular RNS announcements
throughout 2024 to date. Most notably, they report significantly improved
operating performance and enhanced revenue generation at Pyebridge. Pyebridge
also benefited from extended periods of low winds during the last quarter of
2024 which sent UK power prices to a multi-year high, with the intraday price
for electricity surging to c. £600 per MWh during December 2024.

 

Following successful pre-qualification for additional Capacity Market ("CM")
T-1 and T-4 contracts during the assessment window in August 2024, and the
implementation of a robust CM auction bid strategy, for the first time
Pyebridge has now successfully secured both contracts at its maximum
generation capacity permissible under the CM rules. The recent CM T-4 auction
cleared at £60,000 per MW/year, and the CM T-1 auction cleared at £20,000
per MW/year. This means that Pyebridge now has uninterrupted CM contracts
until 2029 with a cumulative total guaranteed gross profit income value of c.
£1.73m, over and above its trading income through the Statkraft Power
Purchase Agreement ("PPA") and Embedded Benefits.

 

Since the signing of the loan facility with RiverFort in February 2024, I am
glad to report that our relationship has deepened and broadened over 2024
culminating in the signing of a Project Finance Framework Agreement  in
November 2024 providing for RiverFort  to  support MED to procure and secure
project finance funding in order to grow its portfolio of in production to
300+ MW's, and further provide MED with certain financial advisory support
services. Commensurate with the signing of the Project Finance Framework
Agreement, we also announced the sale of our greenfield Rochdale Project at a
premium to the initial acquisition cost. This sale was in line with our
refocused strategy to acquire existing constructed or advanced sites which
have a lower total investment cost and shorter time to production and income
generation than earlier stage development sites. The sale also provided
additional cashflow to the Company to expedite its refocused acquisition
strategy and for general working capital purposes.

 

In addition to the Rochdale sale, we have continued to examine how we can best
achieve value from our remaining three early construction and development
sites, Bordesley, Hindlip and Stather while acquiring additional more advanced
projects in line with our refocused strategy as mentioned above.   In this
regard, I am pleased to reflect on MED's new Growth Capital Partnership with
long-established and successful UK flexible power developer and operator,
Powertree (Holdings) Ltd ("Powertree"), to form a long-term partnership with
MED and deploy capital into the portfolio of development flexible power
generation projects that MED owns or acquires, starting with Hindlip.  As
part of this Growth Capital Partnership, Powertree and ADV 0001 Limited (MED's
SPV holding the Hindlip Project), signed an interim finance facility agreement
for an initial advance of up to £70,000 of which MED availed of the full
amount to cover some of Hindlip site's on-going development costs. Subsequent
to the signing of the finance facility MED has now entered a comprehensive
investment agreement with Powertree for the construction of Hindlip under the
terms of the Growth Capital Partnership. This comprises an investment
agreement and a revision of the existing finance facility to provide capital
funding for Hindlip up to £5m, resulting in the Hindlip site being fully
funded with no further funding obligation from MED. The Growth Capital
Partnership, which we expect will be extended to MED's other development and
pipeline projects should assist with accelerating the timeframe to our
objective to reach a 300+ MW portfolio acquiring, developing and operating
multiple small-scale flexible power generation plants across the UK. In terms
of pipeline projects, MED and its partners continue to identify potential
acquisition opportunities with the objective to grow MED's portfolio of MWs in
production at some pace.

 

With regard to corporate matters, following MED's successful agreement on the
reprofiling of the outstanding balances on MED's two existing loan facilities
held with RiverFort in May 2023, the Company paid down £325,000 on the
outstanding balance in May 2024 via a director loan purchase agreement and a
placing, and also secured funding of £325,000 via a new non-convertible fixed
term loan with RiverFort. The placing, which was facilitated by the company's
broker, Novum Securities, was at a price of 0.20p per share resulting in the
issue of an additional 162,500,000 shares during 2024. I am also pleased to
welcome Fortified Securities who were appointed in November 2024 as an
additional corporate broker. Together with Novum Securities. I am confident
that they will greatly assist the Company with its future funding
requirements. Towards the end of 2024 we also saw Louis Coetzee and Dominic
Traynor step-down and retire as directors of MED to pursue other business
interests, and I would like to thank them for their significant contributions
to the development of the Company while they served as directors.

 

I would like to extend a special word of thanks and appreciation on behalf of
the Company and its board of directors to RiverFort, which was instrumental in
ensuring MED's successful business turnaround during 2024 and continues to
provide significant support to the Group.

 

As I write, changes in the global geopolitical environment are rapid, with the
threat of a global tariff war on the horizon as well as uncertainty on the
outcomes of conflicts in Ukraine and the Middle East and their impact on UK
and European energy markets. When added to the impact of the evolving UK
Government response to climate change and changes to the regulatory
environment, I believe we have to be prepared for volatility in energy markets
and prices for the foreseeable future. However, MED remains confident and
optimistic that our business strategy and new partner relationships will
enable the Group to deliver positive results from a growing robust projects
portfolio over the course of the next 12 months and beyond.

 

In conclusion I would like to thank Pieter Krügel and his management team for
their ongoing execution of the MED business strategy which has seen
significant positive progress during 2024 following the challenging events the
Company faced during 2023, and I look forward to supporting them as we build
towards our target of 300+ MWs of flexible power generation available to the
UK energy market.

 

This report was approved on 29 April 2025 by:

 

 

Paul Venter

Non-Executive Chairman

 

 

 

Financial summary of the MAST Energy Developments PLC Group

 

The following information is included to highlight the financial performance
of the Group in its inaugural period of operations.

 

 Description                                       Year ended         Year ended

                                                   31 December 2024   31 December 2023
 Revenue                                           737,158            341,207
 Cost of sales                                     (441,541)          (223,838)
 Gross profit                                      295,617            117,369
 Administrative expenses                           (764,441)          (941,941)
 Listing and capital raising fees                  (130,421)          (464,853)
 Project expenditure                               (340,582)          (343,718)
 Impairment                                        -                  (1,857,604)
 Disposal/de-recognition of non-current asset      87,005             -
 Other income                                      -                  40,375
 Finance income                                    18                 1,117
 Finance costs                                     (244,629)          (90,139)
 Loss for the period                               (1,097,433)        (3,539,394)

 

The decrease in the loss year-on-year, as disclosed in the table above and in
the statement of comprehensive income, is mainly owing to the following
reasons:

•           Revenue increased 77% year-on-year due the
comprehensive refurbishment programme started at Pyebridge earlier in 2024 in
partnership with RiverFort and the successful completion of the overhaul of
two engines at the Pyebridge site. The first overhauled engine was
commissioned in July 2024, and the second during December 2024. The increase
in cost of sales is directly aligned with the increase in revenue.

•           Pyebridge successfully qualified for and secured a
number of Capacity Market ("CM") contracts, the first being a T-1 CM contract
for delivery year 2023/2024 and the second CM for the delivery year 2024/2025,
contributing to increased revenue earnings compared to 2023.

•           Administrative expenses reduced with 19% year-on-year,
due to concerted efforts to reduce costs.

•           Listing and capital raising fees reduced with 72%
year-on-year since new shares were only issued on one occasion during 2024.

•           The impairment expense in 2023 was high due the
pressure on the UK economy which influenced the assumptions used by management
for the impairment assessment. There were no impairments recognised in 2024
largely due to the current improved market conditions, most notably the
inflation and interest rate environment that have stabilised since 2023.
Possible impairment reversals were identified during the impairment assessment
performed as at year-end, but are not recognised in the accounts until it is
confirmed to be of more permanent nature. Refer to note 11 for further
details.

•           A gain on disposal of the Rochdale site to the value
of c. £16k.

•           The de-recognition of the Stather Road lease (c.
£70k) that was due to a Deed of Variation signed during 2024 resulting in the
lease liability and corresponding right-of-use asset being de-recognised in
terms of IFRS16. Due to the asset being impaired in 2023, it is showing as a
gain in 2024.

 

There have been no dividends declared or paid during the current financial
period (2023: £ Nil).

 

 

 

REPONSIBILITY STATEMENT

 

We confirm to the best of our knowledge:

a)    the condensed set of financial statements has been prepared in
accordance with IAS 34 'Interim Financial Reporting';

b)   the Directors' Statement includes a fair review of the information
required by the Disclosure and Transparency Rule DTR 4.2.7R (indication of
important events during the year); and

c)    the Directors' Statement includes a fair review of the information
required by the Disclosure and Transparency Rule DTR 4.2.8R (disclosure of
related party transactions and changes therein); and

d)   this report contains certain forward-looking statements with respect to
the operations, performance, and financial condition of the Group. By their
nature, these statements involve uncertainty since future events and
circumstances can cause results and developments to differ materially from
those anticipated.

 

The forward-looking statements reflect knowledge and information available at
the date of preparation of this financial report and the Company undertakes no
obligation to update these forward-looking statements.

 

Nothing in this financial report should be construed as a profit forecast.

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

                                                        Group
                                                        Year ended         Year ended

                                                        31 December 2024   31 December 2023
                                                        Audited            Audited
                                               Note     £                  £

 Revenue                                                737,158            341,207
 Cost of sales                                          (441,541)          (223,838)
 Gross profit/(loss)                                    295,617            117,369
 Administrative expenses                                (764,441)          (941,941)
 Listing and other corporate fees                       (130,421)          (464,853)
 Project expenditure                                    (340,582)          (343,718)
 Impairment                                    7&8      -                  (1,857,604)
 Operating loss                                         (939,827)          (3,490,747)
 Other income                                           87,005             40,375
 Finance income                                         18                 1,117
 Finance costs                                          (244,629)          (90,139)
 Loss before tax                                        (1,097,433)        (3,539,394)
 Taxation                                                                  -
 Loss for the period                                    (1,097,433)        (3,539,394)
 Total comprehensive loss for the period                (1,097,433)        (3,539,394)

 Loss for the period                                    (1,097,433)        (3,539,394)
 Attributable to the owners of the parent               (1,097,433)        (3,539,394)
 Attributable to the non-controlling interest           -                  -

 Total comprehensive loss for the period                (1,097,433)        (3,539,394)
 Attributable to the owners of the parent               (1,097,433)        (3,539,394)
                                                        -
 Loss Per Share
 Basic loss per share(pence)                   6        (0.32)             (1.51)
 Diluted loss per share(pence)                 6        (0.32)             (1.51)

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2024

                                          Group
                                          31 December  31 December

                                          2024         2023
                                          Audited      Audited
                                    Note  £            £
 Assets
 Non‑Current Assets
 Property, plant and equipment      7     3,278,530    2,080,869
 Intangible assets                  8     247,405      397,779
 Total non-current assets                 3,525,935    2,478,648

 Current Assets
 Other receivables                        364,469      122,649
 Cash and cash equivalents                146,446      252
 Total current assets                     510,915      122,901

 Total Assets                             4,036,850    2,601,549

 Equity and Liabilities
 Equity
 Called up share capital            10    426,354      263,854
 Share premium account              10    13,326,277   13,183,277
 Share reserve                            -            81,329
 Warrant reserve                    12    400,241      380,741
 Common control reserve             11    383,048      383,048
 Non-controlling interest acquired  11    (4,065,586)  (4,065,586)
 Retained deficit                         (11708,605)  (10,611,172)
 Total Equity                             (1,238,271)  (384,509)

  Liabilities
  Non-current Liabilities
  Lease liability                   7     341,149      405,390
  Other financial liabilities       14    2,268,089    318,925
  Total non-current liabilities           2,609,238    724,315

  Current Liabilities
  Loans from related parties        13    -            849,253
  Trade and other payables                696,049      941,688
  Other financial liabilities       14    1,965,967    444,365
  Lease liability                   7     3,867        4,205
  CLN Derivative liability          14    -            22,232
  Total current liabilities               2,665,883    2,261,743
  Total Liabilities                       5,275,121    2,986,058

  Total Equity and Liabilities            4,036,850    2,601,549

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

 

                                                                           Share     Share       Share Reserve  Common Control Reserve  Warrant Reserve  Non-controlling interest acquired  Retained deficit  Total

                                                                           Capital   Premium
                                                                           £         £           £              £                       £                £                                  £                 £
 Balance at 31 December 2022                                               217,453   12,653,607  -              383,048                 -                (4,065,586)                        (7,071,778)       2,116,744
 Total comprehensive loss for the period                                   -         -           -              -                       -                -                                  (3,539,394)       (3,539,394)
 Warrants issued during the year                                           -         -           -              -                       380,741          -                                  -                 380,741
 Loans partially settled in shares                                         14,755    92,317      -              -                       -                -                                  -                 107,072
 Director's loan repayable in shares                                       -         -           81.329         -                       -                -                                  -                 81,329
 Loan with holding company settled in shares                               31,646    437,353     -              -                       -                -                                  -                 468,999
 Balance at 31 December 2023                                               263,854   13,183,277  81,329         383,048                 380,741          (4,065,586)                        (10,611,172)      (384,509)
 Total comprehensive loss for the period                                   -         -           -              -                       -                -                                  (1,097,4330)      (1,097,433)
 Shares issued                                                             162,500   143,000     -              -                       19,500           -                                  -                 325,000
 Derecognition of equity component of director's loan repayable in shares  -         -           (81,329)       -                       -                -                                  -                 (81,329)
 Balance at 31 December 2024                                               426,354   13,326,277  -              383,048                 400,241          (4,065,586)                        (11,708,605)      (1,238,271)

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW

 

                                                                    Group
                                                                    Year ended    Year ended

                                                                    31 December   31

                                                                    2024          December

                                                                                  2023
                                                                    Audited       Audited
                                                              Note  £             £

 Cash flows from operating activities
 Loss for the period before taxation                                (1,097,433)   (3,539,394)

 Adjustments for non-cash items:
 Depreciation                                                 7     78,894        74,542
 Impairment of intangible assets                              8     -             1,397,904
 Impairment of PPE                                                  -             459,700
 Gains on disposal of non-current assets                            (87,005)
 Implementation fee on reprofiling of convertible loan notes        -             48,950
 Loss/(gain) on revaluation of CLN derivative liabilities           -             86,558
 Non-cash interest accrued                                          244,629       88,731
 Amounts due settled from share issue proceeds                      64,500        -
 Amounts due settled from Rochdale disposal proceeds                41,234        -
 Other non-cash items                                               11,451        369
                                                                    (743,730)     (1,382,640)
 Movement in working capital
 Decrease/(increase) in debtors                                     (241,820)     14,152
 Increase in creditors                                              (245,639)     641,363
                                                                    (487,459)     655,515
 Net cash outflows from operating activities                        (1,231,189)   (727,125)

 Cash flows from investing activities
 Disposal of subsidiary                                             216,936       -
 Property, plant and equipment acquired                             (1,636,555)   -
 Property, plant and equipment disposed                             270,000       -
 Net cash outflows from investing activities                        (1,149,619)   -

 Cash flows from financing activities
 Lease liability repaid                                       7     (39,826)      (39,292)
 Loans from related parties repaid                            13                  -
 Proceeds from convertible loan notes                         14    -             85,800
 Proceeds from term loan                                            2,839,297     -
 Repayment of term loan                                             (529,969)     -
 Repayments of director's loan                                      (3,000)       -
 Shares issued net of share issue costs                             260,500       -
 Proceeds from director's loan                                      -             81,329
 Proceeds from shareholder's loan                                   -             86,615
 Warrants issued                                                    -             380,741
 Net cash flows financing activities                                2,527,002     595,193

 Net (decrease) / increase in cash and cash equivalents             146,194       (131,932)
 Cash and cash equivalents at beginning of period                   252           132,184
 Cash and cash equivalents at end of the period                     146,446       252

 

 

 

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED ANNUAL FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

 

Note 1: General information

 

MAST Energy Developments PLC ('MAST' or 'MED' or the 'Company') is
incorporated in England & Wales as a public limited company. The Company's
registered office is located at 55 Ludgate Hill, London, United Kingdom, EC4M
7JW.

 

The principal activity of MAST, through its subsidiaries (together the
'Group'), is to acquire and develop a portfolio of flexible power plants in
the UK and become a multi-asset operator in the rapidly growing Reserve Power
market.

 

Note 2: Statement of Preparation

 

The Group and Company's financial statements have been prepared in accordance
with international accounting standards in conformity with the requirements of
the Companies Act 2006 and international financial reporting standards adopted
by the United Kingdom. The individual financial statements of the Company
("Company financial statements") have been prepared in accordance with the
Companies Act 2006 and UK adopted international financial reporting standards.

 

Note 3: Consolidation

 

The consolidated annual financial statements comprise the financial statements
of MAST Energy Developments PLC and its subsidiaries for the year ended 31
December 2024, over which the Company has control.

 

Control is achieved when the Company:

·    has the power over the investee;

·    is exposed, or has rights, to variable return from its involvement
with the investee; and

·    has the ability to use its power to affect its returns.

 

In assessing control, potential voting rights that are currently exercisable
or convertible are taken into account. Subsidiaries are fully consolidated
from the date that control commences until the date that control ceases.
Accounting policies of subsidiaries have been changed where necessary to
ensure consistency with the policies adopted by the Group. Intragroup balances
and any unrealised gains or losses or income or expenses arising from
intragroup transactions are eliminated in preparing the Group financial
statements, except to the extent they provide evidence of impairment.

 

The Group accounts for business combinations using the acquisition method of
accounting. The cost of the business combination is measured as the aggregate
of the fair values of assets given, liabilities incurred or assumed and equity
instruments issued. Costs directly attributable to the business combination
are expensed as incurred, except the costs to issue debt which are amortised
as part of the effective interest and costs to issue equity which are included
in equity.

 

The acquiree's identifiable assets, liabilities and contingent liabilities
which meet the recognition conditions of IFRS 3 Business Combinations are
recognised at their fair values at acquisition date.

 

Contingent liabilities are only included in the identifiable assets and
liabilities of the acquiree where there is a present obligation at acquisition
date.

 

Non-controlling interest arising from a business combination is measured
either at their share of the net asset value of the assets and liabilities of
the acquiree or at fair value. The treatment is not an accounting policy
choice but is selected for each individual business combination, and disclosed
in the note for business combinations.

 

Changes in the Group's interest in subsidiaries that do not result in a loss
of control are accounted for as equity transactions.

 

Note 4: Going concern

 

The financial results have been prepared on the going concern basis that
contemplates the continuity of normal business activities, the realisation of
assets and the settlement of liabilities in the normal course of business.

 

The financial results have been prepared on the going concern basis that
contemplates the continuity of normal business activities, the realisation of
assets and the settlement of liabilities in the normal course of business.

 

In performing the going concern assessment, the Board considered various
factors, including the availability of cash and cash equivalents, data
relating to working capital requirements for the foreseeable future, cashflows
from operational activities, available information about the future, the
possible outcomes of planned events, changes in future conditions,
geopolitical events (e.g. escalation of the Ukraine conflict), and the
responses to such events and conditions that would be available to the Board.

 

The Board has, inter alia, considered the following specific factors in
determining whether the Group is a going concern:

·    The total comprehensive loss for the year of £1,097,433 compared to
£3,539,394 for the preceding 12 month-financial period;

·    Cash and cash equivalents available to the Group in the amount of
£146,446 in order to partially pay its creditors and maturing liabilities
(excluding the Pyebridge facilities) in the amount of £2,558,320; and

·    MED and Pyebridge has a secured funding facility of up to GBP 4
million from RiverFort, of which the Company has drawn £2,769,297. The main
focus of the facility is to overhaul the Pyebridge gensets in order to get the
site generating at its full efficiency and income potential. The current
outstanding balance is £2,131,328 following repayments totalling £637,969.

·    Whether the Group has available cash resources, or equivalent short
term funding opportunities in the foreseeable future, to deploy in developing
and growing existing operations or invest in new opportunities.

·      Post reporting period end, on 20 March 2025, the Company
announced it has signed a binding definitive investment agreement (the
"Investment Agreement") with Powertree (Holdings) Ltd ("Powertree"). Under
the Investment Agreement, Powertree will invest up to £5,000,000 into
MED's Hindlip project (the "Investment Consideration"), resulting in the
Hindlip project being fully funded.

 

The Directors have evaluated the Group's liquidity requirements to confirm the
Group has adequate cash resources to continue as a going concern for the
foreseeable future. Considering the net current liability position, the
Directors have reviewed financial projections to 30 August 2026 which include
estimates and assumptions regarding the future revenues and costs and timing
of these. The financial projection includes non-committed capex expenditure
for the overhaul of the third Pyebridge engine. Thereby projecting revenue for
up to three revenue producing Pyebridge engines during 2025. It includes the
signed capacity market contracts income.

 

Based on the cash flow forecast the group experiences cash shortfall
throughout the forecast period, ending with a shortfall of c. £286,000 at the
end of Aug 2026. The cashflow forecast is reliant on a successful drawdown on
a current facility, as well as successful electricity generation by Pyebridge.
Unforeseen challenges with either of the aforementioned cause a risk that the
Company may not be able to meet its current liabilities without another cash
injection. In the event that further funding cannot be secured, the Group may
experience continuous cash shortfalls over the next 18 months. The directors
are in negotiations with funders and lenders to upgrade and/or develop the
sites as per the business model of the Company.

 

In response to the net current liability position and to address future
cashflow requirements, detailed liquidity improvement initiatives have been
identified and are being pursued, with their implementation regularly
monitored in order to ensure the Group is able to alleviate the liquidity
constraints in the foreseeable future. Cost saving measures were identified
and implemented on operational expenditure.

 

The Group has identified the below options in order to address the liquidity
risk the Group faces on an ongoing basis. The ability of the Group to continue
as a going concern is dependent on the successful implementation or conclusion
of one or more of the below:

·    The successful drawdown on the funding facility of £4,000,000 with
RiverFort. There are terms and conditions limiting the drawdown which has to
be adhered to.

·    Raising of short- and medium term working capital and project capex
funding, by way of capital placings.

·    Successful conclusion of current funding opportunities of the Group
with strategic funders regarding the funding of specific projects and/or the
business.

·    Obtaining debt funding or other funding instruments such as credit
loan notes to fund MED projects.

·    Successful cash generation from the Pyebridge power-generation
facilities in order to achieve net-cash positive contributions toward the
larger Group.

 

Although there is no guarantee, the Directors have a reasonable expectation
that the Group will be able to raise further financing to support its ongoing
development and commercialisation activities and continue in operational
existence for the next 12 months, from date of sign off of these financial
statements. The directors have concluded that the combination of these
circumstances represents a material uncertainty that casts significant doubt
upon the Group's ability to continue as a going concern and that, therefore,
the Group may be unable to realise its assets and discharge its liabilities in
the normal course of business. As the Board is confident it would be able to
successfully implement the above responses, it has adopted the going concern
basis of accounting in preparing the consolidated financial statements.

 

Note 5: Segmental Reporting

 

The Group discloses segmental analysis based on its different operations,
being Bordersley, Rochdale . ADV 001 (Hindlip Lane), ARL 018 (Stather Road)
and Pyebridge

 

 31 December 2024                   ADV001 Hindlip Lane  ARL018 Stather Road  Bordersley   Rochdale  Pyebridge    Treasury and Investment  Group
                                    (£)                  (£)                  (£)          (£)       (£)          (£)                      (£)
 Revenue                            -                    -                    -            -         737,158      -                        737,158
 Cost of sales                      -                    -                    -            -         (441,541)    -                        (441,541)
 Administrative and other expenses  (36,470)             (9,820)              (9,248)      (2,616)   (73,218)     (763,490)                (894,862)
 Depreciation                       -                    -                    -            -         (77,305)     (1,589)                  (78,894)
 Project costs                      (2,278)              (512)                (6,717)      (1,171)   (299,424)    48,414                   (261,688)
 Other income                       -                    70,673                                                   16,350                   87,023
 Finance costs                      (230)                (3,690)              (29,309)     -         (136,329)    (75,071)                 (244,629)
 Operating profit/(loss)            (38,978)             56,651               (45,274)     (3,787)   (290,659)    (775,386)                (1,097,433)

 Total assets                       110,597              5,248                50,749       -         3,591,046    279,210                  4,036,850
 Capital expenditure                -                    -                    -            -         1,636,555    -                        1,636,555
 Total liabilities                  (128,077)            (59,657)             (398,656)    -         (2,595,350)  (2,093,381)              (5,275,121)

 31 December 2023                   ADV001 Hindlip Lane  ARL018 Stather Road  Bordersley   Rochdale  Pyebridge    Treasury and Investment  Group
                                    (£)                  (£)                  (£)          (£)       (£)          (£)                      (£)
 Revenue                            -                    -                    -            -         341,207      -                        341,207
 Cost of sales                      -                    -                    -            -         (223,838)    -                        (223,838)
 Administration and other expenses  (14,032)             (20,313)             (37,736)     (9,377)   (46,424)     (1,319,017)              (1,447,169)
 Impairment                         -                    (208,398)            (1,649,206)  -         -            -                        (1,857,604)
 Project costs                      (38,434)             (5,743)              (27,972)     (23,396)  (173,631)    -                        (296,176)
 Other income                       -                    -                    -            -         126,933      (86,558)                 40,375
 Depreciation                       -                    (2,509)              (11,941)     -         (58,504)     (1,589)                  (74,542)
 Operating loss                     (52,736)             (236,963)            (1,726,855)  (32,773)  (34,257)     (1,407,163)              (3,490,747)

 Total assets                       9,163                117,215              392,155      91,134    2,020,584    28,702                   2,658,953
 Total liabilities                  (25,979)             (139,276)            (389,225)    (38,391)  (174,537)    (2,218,650)              (2,986,058)

 

As the Group currently operates solely from the United Kingdom, consequently
there is no segmented disclosure with regard to different geographic areas of
operation.

 

Note 6: Loss per share

 

Basic loss per share

The basic loss and weighted average number of ordinary shares used for
calculation purposes comprise the following:

 

 Basic loss per share                                                             31 December 2024 (£)   31 December 2023 (£)
 Loss for the period attributable to equity holders of the parent                 (1,097,433)            (3,539,394)

 Weighted average number of ordinary shares for the purposes of basic loss per    340,131,101            234,172,196
 share

 Basic loss per ordinary share (pence)                                            (0.32)                 (1.51)

 

The Group has no dilutive instruments in issue as at year end.

 

Note 7: Property, plant and equipment

 

 Group                                  Land      Plant & Machinery      Right of use assets  Computer Equipment  Asset under construction  Total
 Cost                                   (£)       (£)                    (£)                  (£)                 (£)                       (£)
 Opening Cost as at 1 January 2024      602,500   1,538,629              418,157              4,766               126,800                   2,690,852
 Derecognition of leases                -         -                      (62,717)             -                   -                         (62,717)
 Additions                              -         1,604,340              -                    -                   32,215                    1,636,555
 Disposals                              (90,000)  (270,000)              -                    -                   -                         (360,000)
 Closing Cost as at 31 December 2024    512,500   2,872,969              355,440              4,766               159,015                   3,904,690

 Accumulated Depreciation ("Acc Depr")  (£)       (£)                    (£)                  (£)                 (£)                       (£)
 Opening Acc Depr as at 1 January 2024  -         (111,136)              (418,157)            (2,340)             (78,350)                  (609,983)
 Depreciation                           -         (77,306)               -                    (1,588)             -                         (78,894)
 Derecognition of leases                -         -                      62,717               -                   -                         62,717
 Acc Depr as at 31 December 2024        -         (188,442)              (355,440)            (3,928)             (78,350)                  (626,160)

 Carrying Value                         (£)       (£)                    (£)                  (£)                 (£)                       (£)
 Carrying value as at 31 December 2023  602,500   1,427,493              -                    2,426               48,450                    2,080,869
 Carrying value as at 31 December 2024  512,500   2,684,527              -                    838                 80,665                    3,278,530

 

During the year, the Group reassessed its property, plant and equipment's
value in use and found that the conditions that previously lead to its
impairment have improved. This has led to reversal of impairments.

 

 Right of use asset                                                             31 December 2024(£)   31 December 2023(£)

                                                                                Group                 Group
 Set out below are the carrying amounts of right-of-use assets recognised and
 the movements during the period:
 Opening balance                                                                -                     333,525
 Change in lease                                                                -                     62,274
 Impairment                                                                     -                     (381,350)
 Depreciation                                                                   -                     (14,449)
 Closing balance                                                                -                     -

 Lease liability
 Set out below are the carrying amounts of lease liabilities and the movements
 during the period:
 Opening balance                                                                409,595               350,654
 Interest                                                                       35,621                35,959
 Change in lease                                                                (60,373)              62,274
 Repayment                                                                      (39,826)              (39,292)
 Closing balance                                                                345,016               409,595

 Split of lease liability between current and non-current portions:
 Non-current                                                                    341,149               405,930
 Current                                                                        3,867                 4,205
 Total                                                                          345,016               405,595

 

 Future minimum lease payments fall due as follows
 - within 1 year                                    32,866     39,826
 - later than 1 year but within 5 years             159,304    159,304
 - later than 5 years                               690,186    851,812
 Subtotal                                           854,516    1,050,942
 - Unearned future finance charges                  (537,340)  (641,347)
 Closing balance                                    345,016    409,595

The Group has two lease contracts for land it shall utilise to construct
gas-fuelled power generation plants. The land is located at Bordesley,
Liverpool St. Birmingham and Stather Road, Flixborough. The Stather Road lease
has been derecognised following deed of variations entered into with the
lessors delaying the inception date of the lease until such time that the
conditions linked to the inception date are met. There is no clear indication
of the date in which the conditions will be met.

 

The lease of the land has a lease term of 20 years, with an option to extend
for 10 years which the Group has opted to include due to the highly likely
nature of extension as at the time of the original assessment.

 

The Group's obligations under its leases are secured by the lessor's title to
the leased assets. The Group's incremental borrowing is 10.38%.

 

Note 8: Intangible assets

 

Intangible assets consist of separately identifiable assets, property rights
or intellectual property (Bordersley Power) acquired either through business
combinations or through separate asset acquisitions. These intangible assets
are recognised at the respective fair values of the underlying asset acquired,
or where the fair value of the underlying asset acquired is not readily
available, the fair value of the consideration.

 

The following reconciliation serves to summarise the composition of intangible
assets as at period end:

 

 Group                                  Rochdale Power (£)   Bordersley Power (£)   ARL018 Stather Road (£)   ADV001 Hindlip Lane (£)   Total (£)
 Carrying value as at 1 January 2023    150,273              1,306,422              91,482                    247,506                   1,795,683
 Impairments                            -                    (1,306,422)            (91,482)                  -                         (1,397,904)
 Carrying value as at 31 December 2023  150,273              -                      -                         247,506                   397,779
 Disposal of Rochdale Power             (150,273)            -                      -                         -                         (150,273)
 Modification                           -                    -                      -                         (101)                     (101)
 Carrying value as at 31 December 2024  -                    -                      -                         247,405                   247,405

 

Note 9: Acquisition of interests in other entities

 

Sloane Energy Limited - 2023

 

During 2023, Sloane Developments (Sloane) founded and acquired 100% equity
interest in Sloane Energy Limited. At the reporting date the company was
dormant.

 

Rochdale Power Limited - 2024

 

During 2024, Sloane disposed of its interest in Rochdale Power Limited for an
amount of £258,170. The proceeds were applied against amounts due by Rochdale
with the remainder of £216,936 paid to the Group. The net asset value of the
project assets and liabilities at disposal date was £200,603. The group
recognised a profit on disposal of £16,333.

 

Note 10: Share Capital

 

The called-up and fully paid share capital of the Company is as follows:

                                                                      2024                   2023
 Allotted, issued and fully paid shares
 (2024: 426,354,067 Ordinary shares of £0.001 each)                   £426,354               -
 (2023: 263,854,067 Ordinary shares of £0.001 each)                   -                      £263,854
                                                                      £426,354               £263,854

                              Number of Shares    Ordinary Share Capital            Share Premium

(£)
(£)
 Balance at 31 December 2023  263,854,067         263,854                           13,183,277
 Issue of shares              162,500,000         162,500                           143,000
 Balance at 31 December 2024  426,354,067         426,354                           13,326,277

 

All ordinary shares issued have the right to vote, right to receive dividends,
a copy of the annual report, and the right to transfer ownership of their
shares.

 

The group and company issued the following ordinary shares during the period,
with regard to key transactions:

• 162,500,000 new MED Shares of £0.001 each were issued on 7 May 2024 at a
deemed issue price of £0.002 for £325,000 of which £64,500 was applied
against share issue costs and accrued brokers fees.

 

Note 11: Reserves

 

Common control reserve

 

The common control reserve is the result of the capital reorganisation between
the company, its holding and ultimate holding company during the 2020
financial year. As the reorganisation was outside the scope of IFRS 3,
predecessor valuation accounting was applied as a result of the common control
transaction. The common control reserve amounts to £383,048 (2023:
£383,048).

 

Non-controlling interest acquired

 

On 31 July 2020, Sloane Developments Limited, MAST Energy Projects Limited and
St. Anderton on Vaal Limited entered into the Share Exchange Agreement
relating to the acquisition by Sloane Developments Limited of the remaining
40% of the issued share capital of MAST Energy Projects Limited. Under the
Share Exchange Agreement, the Company paid St Anderton on Vaal Limited the sum
of £4,065,586 payable by the issue of 36,917,076 ordinary shares of £0.001
each in the Company. Completion of the Share Exchange Agreement was subject to
and conditional upon the Admission of Mast Energy Developments Limited to the
London Stock Exchange.

 

Following the completion of the IPO on 14 April 2021, the Group acquired the
remaining equity interest in MAST Energy Projects Ltd for the consideration
equal to 36,917,076 shares at a total value of £4,065,586. As the controlling
stake in the entity had already been acquired and was under control of MED,
the transaction was seen as a transaction with owners, and the financial
impact recognised directly in equity of £4,065,586.

 

The rationale for the transaction was to acquire the remaining equity within
MAST Energy Projects Limited in order to have the exclusive see-through equity
interest in the Bordersley project, held in the form of royalty and revenue
agreements between MAST Energy Projects Limited and Bordersley Power Limited,
from which MED could restructure the Group through its SPV's.

 

Note 12: Warrants

 

The following reconciliation serves to summarise the value attributable to the
warrant reserve as at period end for the Company:

                                       Group and Company (£)
                                       2024          2023
 Opening balance of warrant reserve    380,741       -
 Issue of warrants                     19,500        380,741
                                       400,241       380,741

 

The following reconciliation serves to summarise the quantity of warrants in
issue as at period end:

 

                        Group and Company (£)

                        (number of warrants)
                        2024          2023
 Opening balance        86,814,562    -
 New warrants issued    9,750,000     86,814,562
                        96,564,562    86,814,562

 

The weighted average fair value of the warrants is 0.41p per warrant (2023:
£0.44p)

 

At 31 December 2024 the Group had 96,564,562 warrants outstanding:

 

Warrants

 

   Date of Grant  Issue date   Expiry date  Exercise price  Number granted  Exercisable as at 31 December 2024
   18 May 2023    18 May 2023  18 May 2026  2p              2,255,656       2,255,656
   18 May 2023    18 May 2023  18 May 2026  2p              2,255,656       2,255,656
   18 May 2023    18 May 2023  18 May 2027  0.89p           20,575,813      20,575,813
   18 May 2023    18 May 2023  18 May 2027  1.8p            20,575,813      20,575,813
   18 May 2023    18 May 2023  18 May 2027  0.89p           20,575,812      20,575,812
   18 May 2023    18 May 2023  18 May 2027  1.8p            20,575,812      20,575,812
   29 May 2024    29 May 2024  29 May 2027  0.2p            9,750,000       9,750,000
                                                            96,564,562      96,564,562

   Total contingently issuable shares                       96,564,562      96,564,562

 

Note 13: Loan from related parties

 

                                       Group 2024 (£)   Group 2023 (£)   Company 2024 (£)   Company 2023 (£)
 Amounts falling due within one year:
 Kibo Mining (Cyprus) Limited          -                849,253          -                  -
 Pyebridge Power Limited               -                -                375,047            -
                                       -                849,253          375,047            -

 

The loan is unsecured, carries interest at 0%, and is repayable on demand. The
carrying value of loans from related parties equals their fair value due
mainly to the short-term nature of the liability.

Note 14: Other financial and derivative liabilities

 

 

 Description                                           Liable group company  Group 2024(£)   Group 2023(£)   Company 2024 (£)   Company 2023 (£)

 Amounts falling due within one year:
 Convertible loan notes                                MED                   854,594         444,100         854,594            444,100
 CLN Derivative liability                              MED                   -               22,232          -                  22,232
 Loan - RiverFort                                      Sloane Developments   849,253         -               -                  -
 Term loan - Powertree                                 Hindlip               70,230          -               -                  -
 Term loan - RiverFort                                 Pyebridge             107,563         -               -                  -
 Accrued interest on director's loan                   MED                   5,998           265             5,998              265
 Director's loan                                       MED                   78,329          -               78,329             -
                                                                             1,965,967       466,597         938,921            466,597

 Amounts falling due between one year and five years:
 Convertible loan notes                                MED                   -               318,925         -                  318,925
 Term loan - RiverFort                                 Pyebridge             2,268,089       -               -                  -
                                                                             2,268,089       785,522         -                  785,522
                                                                             4,234,056       785,522         938,921            785,522

 

Convertible loan notes

Convertible loan notes consist of a facility from institutional lenders which
reprofiled the outstanding convertible loan notes held during the previous
financial year. The interest accrues at 9.5% to 10% per annum based on the
terms applied for each advance of the facility. The convertible loan notes
have embedded derivative liabilities which were recognised at fair value.

Term loans

The term loans are from institutional lenders. The interest accrues at 10% to
12% per annum.

·      The "Term loan - Powertree" is payable by the Hindlip project
SPV. The loan was used to pay the Capacity Market deposit. This loan is
payable in full during the 2025 financial year and bears interest at 10% per
annum. The term loan has been rolled up into the investment agreement after
year-end. Refer to note 16.

·      The "Term loan - RiverFort" is payable by the Pyebridge SPV. The
funding was used to overhaul the two engines at the Pyebridge site. The loan
consists of three separate drawdowns all repayable during the 2026 financial
year and bear interest at 12% per annum.

·      The "Loan - Riverfort" is the historic shareholder loan owing by
the Company to its former parent company, Kibo Energy PLC ("Kibo"), which Kibo
sold to RiverFort during 2024. This loan has no fixed repayment terms and is
repayable on demand and bears no interest.

 

Accrued interest on director's loan

The director's loan consists of interest payable on a director's loan which is
to be settled in cash. The interest is accrued at 7% per annum.

Note 15: Related Parties

 

Related parties of the Group comprise subsidiaries, significant shareholders
and the Directors.

 

Relationships

 

Board of Directors/ Key Management

 

 Name             Relationship (Directors of:)
 Paul Venter      PSCD Power 1 Ltd
 Louis Coetzee    Kibo Energy PLC and Katoro Gold PLC (up to July 2024)
 Dominic Traynor  Druces LLP (up to Nov 2024)
 Pieter Krügel    Chief Executive Officer
 Noel O'Keeffe    Director of subsidiaries ADV001 Ltd, ARL018 Ltd and Sloane Energy Limited

 

Other entities over which Directors/key management or their close family have
control or significant influence:

 

 PSCD Power 1 Ltd:                   The Director of PSCD Power 1 Ltd is also a Director of Mast Energy
                                     Developments PLC.

 Kibo Mining (Cyprus) Limited:       Kibo Mining (Cyprus) Limited is the controlling shareholder of Mast Energy

                                   Developments PLC (Up to September 2024).

 Ultimate shareholder                Kibo Energy PLC (Up to September 2024).

 Significant shareholders:           PSCD Power 1 Ltd

 Associated by fellow directorship:  Katoro Gold PLC (Up to June 2024)
                                     Kibo Mining (Cyprus) Limited (Up to July 2024)

MAST Energy Developments PLC is a shareholder of the following companies and
as such are considered related parties:

 

 Directly held subsidiaries:  Sloane Developments Limited
                              Bordersley Power Limited
                              Pyebridge Power Limited
                              ADV 001 Limited
                              ARL 018 Limited
                              Sloane Energy Limited

 

Balances

 

 Name                                                                          Amount (£)   Amount (£)

                                                                               2024         2023
 Kibo Mining (Cyprus) Limited - Loan from related parties owing                -            849,253
 Paul Venter - Director's loan owing (share reserve)                           -            81,329
 Paul Venter - Director's loan owing (liability)                               78,329       -
 Paul Venter - Director's loan owing accrued interest                          5,733        265
 Kibo Energy PLC - Management and administration services accrued              31,170       32,130
 Katoro Gold PLC - Receivable for management services paid on Katoro's behalf  4,246        21,140
 Paul Venter - Director's remuneration due                                     43,500       18,371
 Louis Coetzee - Director's remuneration due                                   47,550       27,000
 Dominic Traynor- Director's remuneration due                                  48,018       17,644
 Pieter Krügel - Director's remuneration due                                   43,844       49,844
 Noel O'Keeffe -Professional services remuneration due                         4,500        9,000
 Druces LLP - Supplier balance for professional services                       52,675       143,732

 

Transactions

 

 Name                                Amount (£)

                                     2024
 Paul Venter - interest on loan      5,733
 Druces LLP - Professional services  84,500

 

As announced in the RNS dated 7 May 2024 the Company has entered into a
partial settlement deed, in relation to the Reprofiled Balance due under the
Reprofiling Agreement. Under the terms of the settlement deed Pieter Krügel,
a director of the Company, purchased from Riverfort £325,000 (the
"Capitalised Balance") of the Reprofiled Balance due, in consideration,
Riverfort was paid £325,000 in cash (the "Acquisition"). The Capitalised
Balance was converted into 162,500,000 new MED ordinary shares of 0.1p (the
"Subscription Shares") at a conversion price of 0.20p per share by Mr. Pieter
Krügel. Following admission of the Subscription Shares, Pieter Krügel has
agreed to sell the Subscription Shares to new investors arranged by the
Company's broker at the same price per share as the Conversion, being 0.20p
for a gross consideration of £325,000.

 

Transactions between the Company and its subsidiaries, which are related
parties, have been eliminated on consolidation. The transactions during the
period between the Company and its subsidiaries included the settlement of
expenditure to/from subsidiaries, working capital funding, and settlement of
the Company's liabilities through the issue of equity in subsidiaries. The
loans from related parties do not have fixed repayment terms and are
unsecured.

Note 16: Events after reporting period

 

Following successful pre-qualification for additional Capacity Market ("CM")
T-1 and T-4 contracts during the assessment window in August 2024, and the
implementation of a robust CM auction bid strategy, for the first time
Pyebridge has now successfully secured both contracts at its maximum
generation capacity permissible under the CM rules. The recent CM T-4 auction
cleared at £60,000 per MW/year, and the CM T-1 auction cleared at £20,000
per MW/year. This means that Pyebridge now has uninterrupted CM contracts
until 2029 with a cumulative total guaranteed gross profit income value of c.
£1.73m, over and above its PPA trading income and Embedded Benefits.

 

The Company has signed a binding definitive investment agreement (the
"Investment Agreement") with Powertree (Holdings) Ltd ("Powertree"). Under
the Investment Agreement, Powertree will invest up to £5,000,000 into
MED's Hindlip project (the "Investment Consideration"), resulting in the
Hindlip project being fully funded. The Investment Consideration will consist
of £500,000 for 75% of the fully diluted ordinary equity of the Hindlip
SPV, ADV 001 Ltd and, up to £4,500,000 will be by way of secured loan
(the "Investor Loan") entered into between Powertree (as the lender) and
the Hindlip SPV (as the borrower). MED shall retain 25% of the fully diluted
ordinary equity of the Hindlip SPV with no further funding obligations. The
closing of the Investment Agreement is subject to customary closing
conditions.

 

Note 17: Commitments and contingencies

 

The Group does not have identifiable material commitments and contingencies as
at the reporting date.

 

Note 18: Principal risks

 

The realisation of the various projects is dependent on the successful
completion of technical assessments, project development and project
implementation and is subject to a number of significant potential risks
summarised as follows, and described further below:

•     Funding risk;

•     Regulatory risk;

•     Commodity risk;

•     Development and construction risk;

•     Staffing and key personnel risk; and

•     Information technology risk.

•     Successful refinancing of the historic shareholder loan amounting
to £849,253 owing by the Company to its former parent company, Kibo Energy
PLC ("Kibo"), which Kibo sold to RiverFort during 2024, resulting in the
deferral of loans payable in the foreseeable future beyond a 12-month period
after sign off of these financial statements.

 

Funding risk

Following the successful conclusion of an Initial Public Offering ('IPO') on
14 April 2021, the Group was able to raise £5.54 million in cash, which was
utilised to further advance the various projects of the Group to date. During
2022, the Group raised a further £650 000 for acquisitions and general
working capital purposes and availed of a further £100,000 during 2023 under
the reprofiled loan with institutional investors agreed in May 2023. During
2024, the Company continued to avail of loan facilities under a facility
agreement with RiverFort on which £2,769,297 has been drawn down to date, and
£637,969 has been repaid. Funds from a broker sponsored placing of £350,000
were raised and funds from a second loan facility with RiverFort on which
£350,000 was drawn down coincident with a partial re-settlement of the same
amount on the outstanding balance on the May 2023 reprofiled loan.

 

There can be no assurance that such funds will continue to be available on
reasonable terms, or at all in future, and that projects will be completed
within the anticipated timeframes to supplement cashflows through operational
activities. This risk was realised to a significant extent during 2023 where
anticipated funding from the Seira and subsequently, Proventure joint venture
agreements, did not materialise and has delayed the Company's anticipated
timeframes for project completion.

 

The Group generated revenue of £737,158 (2023: £341,207) for the period
ended 31 December 2024 and had a net liability position of £1,238,271 (2023:
£384 509) as at 31 December 2024. As at year end, the Group had liquid
assets in the form of cash and cash equivalent and other receivables of
£146,446 and £364,469 (year to 31 December 2023: £122,901), respectively.

 

The Directors have reviewed budgets, projected cash flows and other relevant
information, and based on this review and the rationale set out below, they
are confident that the Group will have adequate financial resources to
continue in operational existence for the foreseeable future.

 

The budgets and projected cash flows are reliant on continued successful
drawdowns on current loan facilities, as well as continued operation of
Pyebridge and its anticipated revenue generation from electricity production.
Unforeseen challenges with either of the aforementioned cause a risk that the
Company may not be able to meet its current liabilities without another cash
injection. The directors have concluded that the combination of these
circumstances represents a material uncertainty that casts significant doubt
upon the Group's ability to continue as a going concern and that, therefore,
the Group may be unable to realise its assets and discharge its liabilities in
the normal course of business.

 

The Directors continue to review the Group's options to secure additional
funding for its general working capital requirements as well as project
financing for commercial production-ready sites, alongside its ongoing review
of anticipated revenue generation from existing sites, potential acquisition
targets and corporate development needs. The Directors are confident that such
funding will be available, although there is no guarantee of such funding. In
addition, any equity funding may be subject to shareholder approvals and in
line with legal and regulatory requirements as appropriate.

 

As a result, the Directors continue to monitor and manage the Group's cash and
overheads carefully in the best interests of its shareholders and believe that
the Company and the Group by successfully implementing the above responses it
will remain a going concern for the foreseeable future.

 

Regulatory risk

The United Kingdom power sector has undergone several considerable regulatory
changes over the last few years and is now at a state of transition from large
fossil-fuel plants to a more diverse range of power-generation sources,
including renewables, small, distributed plants and new nuclear. As a result,
there is greater regulatory involvement in the structure of the UK power
market than has been the case over the last 20 years. Therefore, there remains
a risk that future interventions by Ofgem or Government could have an adverse
impact on the underlying assets that the Group manages and/or owns. The
Company continually monitors this risk and, where possible, acts proactively
to anticipate and mitigate any regulatory changes that may have an adverse
impact on the ongoing financial viability of its projects. To monitor
compliance with evolving UK government energy regulations, the Company
subscribes to relevant environmental and energy regulation bodies' updates
which management reviews on a regular basis. It makes recommendations to the
Board in terms of mitigation that may be required should it become aware of
any pending regulatory changes that may threaten the economic viability of its
projects.

 

Commodity Risk

The assets that the Group manages and owns will receive revenue from the sale
of energy onto the wholesale market or to end users at a price linked to the
wholesale power market price. Volatility in power prices going forward will
affect the profitability of the underlying reserve power assets. For example,
the significant reduction in wholesale electricity prices from 2022 to 2023
resulted in lower electricity prices received from sales at Pyebridge during
the period that it was in operation during 2023.  The Group will also use its
skills, capabilities and knowledge of the UK power market to optimise these
wholesale revenues. The Group's ability to effectively manage price risk and
maximise profitability through trading and risk management techniques with the
assistance of its electricity off-taker and trading platform provider,
Statkraft, will have a considerable impact on the revenues and returns.

 

Climate risk

The Board considers Climate Risk to be a principal risk that may threaten the
business viability of the Company insofar as it informs greater regulatory
involvement by the UK Government in the structure of the UK power market as
discussed under Regulatory Risk above.  As the Company currently relies on
the availability and permitted use of natural gas to fuel its current and
planned reserve power sites, accelerated climate change, and associated
adverse weather events may prompt further restrictions on the use of natural
gas by UK regulators including its phasing out within a shorter period than
the Company currently anticipates.  In order to mitigate this risk, in
addition to keeping itself informed of any pending regulatory risk that may
threaten the economic viability of its projects, the Company will ensure that
the engineering design and location of its projects are amenable to the use of
alternative electricity generating fuels to natural gas e.g. green Hydrogen or
biofuel and at minimum conversion costs should it be required. The Company
will also plan to incorporate alternative renewable energy projects in its
project pipeline such as solar, wind, waste-to-energy or long-duration storage
(battery) do diversify its project portfolio in response to any accelerated
phasing out of natural gas as an electricity generating fuel.  As well as
Climate Risk, the Company also recognises Climate Opportunity and more details
on both are discussed under the Strategy heading in the Task Force on
Climate-related Financial Disclosures (TCFD) section of this report. The TCFD
section, in addition to providing the information required under the TCFD
Framework in compliance with the Listing Rules also includes the Group's
Climate Related Financial Disclosures (CFD)as required under s414C, s414CA and
s414CB of the Companies Act 2006 (the Act).

 

Development and Construction Risk

The Group will continue to develop new project sites that includes obtaining
planning permission, securing land (under option to lease or freehold), and
obtaining gas and grid connections. The Group will also oversee the
construction of these projects where needed.

 

Risks to project delivery include damage or disruption to suppliers or to
relevant manufacturing or distribution capabilities due to weather, natural
disaster, fire, terrorism, pandemic, strikes or other reasons that could
impair the Company's ability to deliver projects on time.

 

Failure to take adequate steps to mitigate the likelihood or potential impact
of development and construction setbacks, or to effectively manage such events
if they occur, could adversely affect the business or financial results. There
are inherent risks that the Group may not ultimately be successful in
achieving the full development and construction of every site and sunk costs
could be lost. However, the risk is mitigated as the Group targets
shovel-ready sites that adhere to specific requirements, coupled with an
experienced senior management team.

 

Staffing and Key Personnel Risks

Personnel are our only truly sustainable source of competitive advantage and
competition for key skills is intense, especially around science, technology,
engineering and mathematics ('STEM') disciplines. While the Group has good
relations with its employees, these relations may be impacted by various
factors. The Group may not be successful in attracting, retaining, developing,
engaging and inspiring the right people with the right skills to achieve our
growth ambitions, which is why staff are encouraged to discuss with management
matters of interest and subjects affecting day-to-day operations of the Group.

 

Information Technology Risks

The Group relies on information technology ('IT') in all aspects of its
business. Any significant disruption or failure, caused by external factors,
denial of service, computer viruses or human error could result in a service
interruption, accident or misappropriation of confidential information.
Process failure, security breach or other operational difficulties may also
lead to revenue loss or increased costs, fines, penalties or additional
insurance requirements. The Group continues to implement more cloud-based
systems and processes and improve cyber security protocols and facilities in
order to mitigate the risk of data loss or business interruption.

 

Note 18: Use of Estimates and Judgements

 

The preparation of financial statements in conformity with IFRS requires
management to make judgements, estimates and assumptions that affect the
application of accounting policies and the reported amounts of assets,
liabilities, income and expenses. The estimates and associated assumptions are
based on historical experience and various other factors that are believed to
be reasonable under the circumstances, the results of which form the basis of
making judgements about carrying values of assets and liabilities that are not
readily apparent from other sources.

 

In particular, there are significant areas of estimation, uncertainty and
critical judgements in applying accounting policies that have the most
significant effect on the amounts recognised in the financial statements.

 

Estimation uncertainty:

Information about estimates and assumptions that may have the most significant
effect on recognition and measurement on assets, liabilities and expenses is
provided below:

 

Impairment assessment of property plant and equipment and intangible assets

In applying IAS 36, impairment assessments are performed whenever events or
changes in circumstances indicate that the carrying amount of an asset or CGU
may not be recoverable. Estimates are made in determining the recoverable
amount of assets which includes the estimation of cash flows and discount
rates used. In estimating the cash flows, management bases cash flow
projections on reasonable and supportable assumptions that represent
management's best estimate of the range of economic conditions that will exist
over the remaining useful life of the assets. The discount rates used reflect
the current market assessment of the time value of money and the risks
specific to the assets for which the future cash flow estimates have not been
adjusted. Refer to Note 11 of the annual report for detailed sensitivity
analysis related to a potential change in the key estimation uncertainties
inherent in the impairment assessment.

 

Useful life of Intangible assets

Amortisation is charged on a systematic basis over the estimated useful lives
of the assets after taking into account the estimated residual values of the
assets. Useful life is either the period of time over which the asset is
expected to be used or the number of production or similar units expected to
be obtained from the use of the asset.

 

 

Estimation uncertainty in the valuation of share-based instruments in issue

Share-based instruments issued, such as warrants or options, or payments made
require significant judgment and estimate concerning the method of valuation
applied and key inputs applied respectively. In order to calculate the charge
for share based warrants issued or payments as required by IFRS 9 and IFRS 2
respectively, the Group makes estimates principally relating to the
assumptions used in its option-pricing model. Refer to Note 12 for details on
valuation of share-based transactions, including options and warrants granted.

 

Useful life of Property, plant and Equipment

The depreciable amounts of assets are allocated on a systematic basis over
their useful lives. In determining the depreciable amount, management makes
assumptions in respect of the residual value of assets based on the expected
estimated amount that the entity would currently obtain from disposing the
asset, after deducting the estimated costs of disposal. If an asset is
expected to be abandoned, the residual value is estimated at £nil. In
determining the useful lives of assets, management considers the expected
period of use of assets, expected physical wear and tear, legal or similar
limits of assets such as rights, condition and location of the asset as well
as obsolescence.

 

Estimation uncertainty in the accrual for variable revenue in relation to
electricity generation

The group's revenue is dependent on the sale of electricity through an offtake
partner based on the quantity of variable units generated over the course of
the year. The utilisation rate is determined by the offtake partner who in
turn relies on on-demand electricity request from the applicable service area.
The group estimates its accrued revenue based on preliminary data received
from the offtake partner which is obtained daily from the portal. Upon receipt
of the final monthly invoice, which is usually in time for year-end reporting
purposes, the estimates are updated to the actual values. No estimation
uncertainties exist over fixed amount contracts for management fees and
capacity market revenues.

 

Critical judgements:

Information about critical judgements that may have the most significant
effect on recognition and measurement on assets, liabilities and expenses is
provided below:

 

Going Concern

The Groups liabilities exceed its assets as at 31 December 2024, mainly due to
the loan from the former ultimate holding company ceded to institutional
investments and convertible loan notes of £849,253 and £854,594 respectively
(2023: loans from related parties £849,253) which contributes significantly
to the material uncertainty related to the going concern assumption applied in
preparation of the financial statements. Management applies judgement in
determining whether or not the Group is able to continue as a going concern
for the foreseeable future, in identifying the matters which give rise to the
existence of the material uncertainty, and in developing responses thereto in
order to address the risk of material uncertainty. Refer to note 4 for further
information on the going concern assessment.

 

Note 19: Financial instruments - Fair value and Risk Management

 

The carrying amount of all financial assets and liabilities approximates the
fair value. Directors consider the carrying value of financial instruments of
a short-term nature, that mature in 12 months or less, to approximate the fair
value of such assets or liability classes.

 

The carrying values of longer-term assets are considered to approximate their
fair value as these instruments bear interest at interest rates appropriate to
the risk profile of the asset or liability class.

 

The Group does not carry any derivative liabilities in the statement of
financial position at fair value at 31 December 2024.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR FFFIISSIAFIE

Recent news on Mast Energy Developments

See all news